This MIcro Cap Found Mid-Week Success On New Clinical Data [Globe and Mail, The (Toronto, Canada)]
IN8bio, Inc. (INAB)
Company Research
Source: Globe and Mail, The
This move could be an indication of things to come as this stock appears to be fighting to break out of the multi-month trading range that has been corralling much of the price action as of late. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. About AllPennyStocks.com Media, Inc.: Founded in 1999, AllPennyStocks.com is one of North America's leading platforms for micro-cap insights. Catering to both Canadian and U.S. markets, we provide a wealth of resources and ex
Show less
Read more
Impact Snapshot
Event Time:
INAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INAB alerts
High impacting IN8bio, Inc. news events
Weekly update
A roundup of the hottest topics
INAB
News
- IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- IN8bio Reports Third Quarter 2025 Financial Results and Recent Business HighlightsGlobeNewswire
- IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New SiteGlobeNewswire
- IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune IndicationsGlobeNewswire
- IN8bio (NASDAQ:INAB) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
INAB
Earnings
- 5/7/25 - Miss
INAB
Sec Filings
- 11/24/25 - Form 8-K
- 11/7/25 - Form S-3
- 11/6/25 - Form 10-Q
- INAB's page on the SEC website